Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Adebanjo J. Adegbola"'
Autor:
Elisha A. Nelson, Ibrahim O. Ahmed, Rahman A. Bolarinwa, Babatunde A. Adeagbo, Adebanjo J. Adegbola, Lateef Salawu, Oluseye O. Bolaji, Muheez A. Durosinmi
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-7 (2024)
Abstract Background In Nigeria, since 2002, Imatinib mesylate (glivec®) has been available freely to chronic myeloid leukaemia (CML) patients but only at a tertiary health care centre in the southwestern part of the country. Despite this, it is not
Externí odkaz:
https://doaj.org/article/230e939148a844e3a98b620494bda0b2
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract Background As per current treatment guidelines, artemether-lumefantrine and efavirenz-based antiretroviral therapy are recommended drugs for falciparum malaria and human immunodeficiency virus (HIV) infections, respectively. A liquid chromat
Externí odkaz:
https://doaj.org/article/0419f1cb7d2641dca37de9ff19725fa7
Autor:
Adebanjo J. Adegbola, Omotade A. Ijarotimi, Akaninyene E. Ubom, Bukola A. Adesoji, Olajide E. Babalola, Emma F. Hocke, Helle Hansson, Andria Mousa, Oluseye O. Bolaji, Michael Alifrangis, Cally Roper
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Background Malaria is a major public health issue with substantial risks among vulnerable populations. Currently, the World Health Organization (WHO) recommends SP-IPTp in the second and third trimesters. However, the efficacy of SP-IPTp is
Externí odkaz:
https://doaj.org/article/57dcc0a36950423ca53c83c38ae04cef
Autor:
Olufunmilola O Abolurin, Adebanjo J Adegbola, Oyeku A Oyelami, Samuel A Adegoke, Oluseye O Bolaji
Publikováno v:
Nigerian Postgraduate Medical Journal, Vol 25, Iss 1, Pp 13-16 (2018)
Background and Aim: Vitamin A deficiency (VAD) constitutes a major nutritional concern in developing countries. It contributes significantly to the morbidity and mortality of under-five children and can result in impaired resistance to infection as w
Externí odkaz:
https://doaj.org/article/294d954fd83f4f5a88fe45ee32da0424
Autor:
Adebanjo J. Adegbola, Akinpelu Ba, Popoola Ok, Faleye Fj, Julius O. Soyinka, Adekeye Dk, Omoniyi Sa
Publikováno v:
Journal of Pharmacognosy and Phytochemistry. 10:01-09
Natural honey is widely applied as food sweetener, food preservative and in folk medicine for treatment of varying degree of human affliction and diseases. This study evaluates the antimicrobial activities, physicochemical, phytochemical and antioxid
Publikováno v:
Journal of Advances in Medical and Pharmaceutical Sciences. :22-32
Back-ground and Objectives: The study’s focus is to investigate the effects of Vernonia amygdalina on the metabolic activities of Cytochrome P450 3A4 and 2D6 in vivo. The assessment was based on CYP2D6-mediated O-demethylation and CYP3A4-mediated N
Publikováno v:
Pharmacogenomics. 21:1289-1297
Aim: We aimed to assess the effect of a functional polymorphism of CYP3A5 on lumefantrine pharmacokinetics. Patients & methods: Sixty-nine women diagnosed with malaria received standard doses of artemether–lumefantrine. Concentration–time data fo
Autor:
Ezekiel Omotoso, Julius O. Soyinkaa, Adebanjo J. Adegbola, Oluseye O. Bolaji, Olujide O. Olubiyi, Cyprian O. Onyeji
Publikováno v:
Journal of Pharmaceutical Research International. :92-105
Lumefantrine contributes significant roles in artemisinin-based combination therapy for malaria treatment but associated with a limitation of poor aqueous solubility and low permeability. This study investigated lumefantrine-2-hydroxypropyl-β-cyclod
Autor:
Adebanjo J. Adegbola, Adeniyi Olagunju, Oluseye O. Bolaji, Babatunde Ayodeji Adeagbo, Andrew Owen, Marco Siccardi, Abutaima Rana, R. A. Bolarinwa
Publikováno v:
Pharmacogenetics and Genomics. 30:96-106
Background Coadministration of artemether-lumefantrine and efavirenz has been shown to result in significant interactions. The influence of functional genetic polymorphisms in selected CYPs on the magnitude of this interaction was investigated in pre
Publikováno v:
Journal of Pharmaceutical Research International. 24:1-23
The oral route of administration is associated with some challenges such as poor aqueous solubility and low intestinal permeability of many active pharmaceutical ingredients resulting in decreased drug absorption and subsequent poor bioavailability.